Matrix Stiffness and Biochemistry Govern Colorectal Cancer Cell Growth and Signaling in User-Programmable Synthetic Hydrogels
- PMID: 40304602
- PMCID: PMC12164295
- DOI: 10.1021/acsbiomaterials.4c01632
Matrix Stiffness and Biochemistry Govern Colorectal Cancer Cell Growth and Signaling in User-Programmable Synthetic Hydrogels
Abstract
Colorectal cancer (CRC) studies in vitro have been conducted almost exclusively on 2D cell monolayers or suspension spheroid cultures. Though these platforms have shed light on many important aspects of CRC biology, they fail to recapitulate essential cell-matrix interactions that often define in vivo function. Toward filling this knowledge gap, synthetic hydrogel biomaterials with user-programmable matrix mechanics and biochemistry have gained popularity for culturing cells in a more physiologically relevant 3D context. Here, using a poly(ethylene glycol)-based hydrogel model, we systematically assess the role of matrix stiffness and fibronectin-derived RGDS adhesive peptide presentation on CRC colony morphology and proliferation. Highlighting platform generalizability, we demonstrate that these hydrogels can support the viability and promote spontaneous spheroid or multicellular aggregate formation of six CRC cell lines that are commonly utilized in biomedical research. These gels are engineered to be fully degradable via a "biologically invisible" sortase-mediated reaction, enabling the triggered recovery of single cells and spheroids for downstream analysis. Using these platforms, we establish that substrate mechanics play a significant role in colony growth: soft conditions (∼300 Pa) encourage robust colony formation, whereas stiffer (∼2 kPa) gels severely restrict growth. Tuning the RGDS concentration did not affect the colony morphology. Additionally, we observe that epidermal growth factor receptor (EGFR) signaling in Caco-2 cells is influenced by adhesion ligand identity─whether the adhesion peptide was derived from collagen type I (DGEA) or fibronectin (RGDS)─with DGEA yielding a marked decrease in the level of downstream protein kinase phosphorylation. Taken together, this study introduces a versatile method to culture and probe CRC cell-matrix interactions within engineered 3D biomaterials.
Keywords: 3D hydrogel model; colorectal cancer; sortase.
Conflict of interest statement
Complete contact information is available at:
The authors declare no competing financial interest.
Similar articles
-
Gelatin vs GelMA in alginate-based bioinks as a platform for versatile 3D bioprintable in vitro systems.Biomater Adv. 2025 Dec;177:214408. doi: 10.1016/j.bioadv.2025.214408. Epub 2025 Jul 9. Biomater Adv. 2025. PMID: 40669326
-
Comparative analysis of 3D-culture techniques for multicellular colorectal tumour spheroids and development of a novel SW48 3D-model.Sci Rep. 2025 Jul 29;15(1):27687. doi: 10.1038/s41598-025-13588-x. Sci Rep. 2025. PMID: 40731083 Free PMC article.
-
Polyethylene Glycol-Based Hydrogel as a 3D Extracellular Matrix Mimic for Cytotoxic T Lymphocytes.J Biomed Mater Res A. 2025 Jan;113(1):e37811. doi: 10.1002/jbm.a.37811. Epub 2024 Oct 21. J Biomed Mater Res A. 2025. PMID: 39429059
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec. Autism Adulthood. 2024. PMID: 40018061 Review.
References
-
- Siegel RL; Miller KD; Goding Sauer A; Fedewa SA; Butterly LF; Anderson JC; Cercek A; Smith RA; Jemal A Colorectal Cancer Statistics, 2020. CA Cancer J. Clin 2020, 70 (3), 145–164. - PubMed
-
- Shen Y; Wang X; Lu J; Salfenmoser M; Wirsik NM; Schleussner N; Imle A; Freire Valls A; Radhakrishnan P; Liang J; Wang G; Muley T; Schneider M; Ruiz de Almodovar C; Diz-Muñoz A; Schmidt T, Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer. Cancer Cell 2020, 37 (6), 800–817.e7. - PubMed
-
- Biller LH; Schrag D Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA 2021, 325 (7), 669–685. - PubMed
-
- Misale S; Yaeger R; Hobor S; Scala E; Janakiraman M; Liska D; Valtorta E; Schiavo R; Buscarino M; Siravegna G; Bencardino K; Cercek A; Chen C-T; Veronese S; Zanon C; Sartore-Bianchi A; Gambacorta M; Gallicchio M; Vakiani E; Boscaro V; Medico E; Weiser M; Siena S; Di Nicolantonio F; Solit D; Bardelli A Emergence of KRAS Mutations and Acquired Resistance to Anti-EGFR Therapy in Colorectal Cancer. Nature 2012, 486 (7404), 532–536. - PMC - PubMed
-
- Crotti S; Piccoli M; Rizzolio F; Giordano A; Nitti D; Agostini M Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? J. Cell. Physiol 2017, 232 (5), 967–975. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous